President's Note: Targeting Mitochondria 2022


On behalf of the Scientific Committee of the World Mitochondria Society (WMS), we are pleased to announce the organization of the 13th Annual Meeting of WMS on Targeting Mitochondria, which will be held on October 26-28, 2022 at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany & Online.

After the great success of the 12thWMS Meeting in 2021 that was held virtually with interactive sessions for discussion, we are hoping that personal interactions among colleagues from around the world will be a major feature of our 13th World Annual Meeting.

While we have just started working on the outline of our next conference edition, we will potentially discuss the following topics:

  • Mitochondrial Dysfunctions and Dynamics in Chronic Diseases
  • Mitochondria Transplantation and Transfer
  • Extracellular Vesicles & Mitochondria: The Target
  • Nuclear-Mitochondrial Interactions and their Effect on Longevity and Health
  • Translational Therapies - Focus on Infrared Therapies
  • WMS challenges in the Acceleration of Mitochondrial Medicine

Basic scientists working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. I assure anyone who is going to join us in this year's Congress in October 2022 that you won’t be disappointed!

We are looking forward to meeting you all!

All our warmest regards.

Prof. Volkmar Weissig
Prof. Volkmar Weissig

President of the World Mitochondria Society
Midwestern University, USA

Prof. Marvin Edeas
Prof. Marvin Edeas, 
Founder of the World Mitochondria Society
Institut Cochin, INSERM U1016, University Paris Descartes, France




Mitochondria in the Press & Media

  • 1
  • 2
Prev Next


News archive